LLY vs BAX
By Alex · Tickerpine
Eli Lilly and Company vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | BAX |
|---|---|---|
| Price | $1,220.28 | $26.95 |
| Market cap | $1.09T | $13.93B |
| P/E ratio | 41.0 | — |
| ROE | 102.29% | -14.37% |
| Profit margin | 33.53% | -9.27% |
| Revenue growth | 47.70% | 5.30% |
| Dividend yield | 0.57% | 0.14% |
| Beta | 0.51 | 0.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs BAX in plain English
- LLY is the bigger company — about 78.1× the market cap of BAX.
- LLY earns a higher return on equity (102% vs -14%).
- LLY is growing revenue faster (48% vs 5%).
- LLY has the higher dividend yield (0.57% vs 0.14%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.